Zvezdan Pirtošek comments on the debate he moderated over whether or not lecanemab should be extended beyond 18 months.
18-03-2024 | Alzheimer's Disease | Video | Article | Supported by: Lilly
Breakfast Bite
18-03-2024 | Alzheimer's Disease | Video | Article | Supported by: Lilly
Zvezdan Pirtošek comments on the debate he moderated over whether or not lecanemab should be extended beyond 18 months.